Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma
© 2017 Rho kinase inhibitors (ROCK II) play a key role in glaucoma management attributed to their IOP lowering ability and neuroprotective effects. In the present study, a series of novel benzimidazole derivatives (9a–m) has been synthesized and evaluated for their IOP lowering, Rho kinase inhibi...
| Main Authors: | Abbhi, V., Saini, L., Mishra, S., Sethi, G., Kumar, Alan Prem, Piplani, P. |
|---|---|
| Format: | Journal Article |
| Published: |
Pergamon
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/73263 |
Similar Items
Pathophysiological role of RhoA/Rho-kinase under oxygen-glucose deprivation/reperfusion and hyperglycaemia
by: Srivastava, Kirtiman
Published: (2013)
by: Srivastava, Kirtiman
Published: (2013)
Roles of Rho-associated kinase in lung cancer review
by: Zakaria, Muhammad Asyaari, et al.
Published: (2020)
by: Zakaria, Muhammad Asyaari, et al.
Published: (2020)
Synthesis And Biological Activity Of Benzimidazole Analogs As Sirtuin Enzyme Inhibitors
by: Yeong, Keng Yoon
Published: (2016)
by: Yeong, Keng Yoon
Published: (2016)
Synthesis of new 1,2-disubstituted benzimidazole analogs as potent inhibitors of Î-Glucuronidase and in silico study
by: Muhammad Taha, et al.
Published: (2021)
by: Muhammad Taha, et al.
Published: (2021)
The adaptor protein 14-3-3 binds to the calcium-sensing receptor and attenuates receptor-mediated Rho kinase signalling
by: Arulpragasam, Ajanthy, et al.
Published: (2012)
by: Arulpragasam, Ajanthy, et al.
Published: (2012)
Antituberculosis: Synthesis and Antimycobacterial Activity of Novel Benzimidazole Derivatives
by: Yeong, Keng Yoon, et al.
Published: (2013)
by: Yeong, Keng Yoon, et al.
Published: (2013)
Further genetic evidence suggesting a role for the RhoGTPase-RhoGEF pathway in osteoporosis.
by: Mullin, B., et al.
Published: (2009)
by: Mullin, B., et al.
Published: (2009)
Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases
by: Zhu, Y., et al.
Published: (2013)
by: Zhu, Y., et al.
Published: (2013)
Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions
by: Gibson, Claire L., et al.
Published: (2014)
by: Gibson, Claire L., et al.
Published: (2014)
Synthesis, characterization and anti-proliferation study of some Benzimidazole derivatives
by: Al-Douh, Mohammed H., et al.
Published: (2011)
by: Al-Douh, Mohammed H., et al.
Published: (2011)
Synthesis, Characterization And Anti-Proliferation Study Of Some Benzimidazole Derivatives
by: al-Douh, Mohammed Hadi Saeed
Published: (2010)
by: al-Douh, Mohammed Hadi Saeed
Published: (2010)
Mechanism Of Action Of A Benzimidazole Sirtuin Inhibitor, Bzd9l1, In Colorectal Cancer
by: Tan, Yi Jer
Published: (2022)
by: Tan, Yi Jer
Published: (2022)
The potential role of boswellic acids in cancer prevention and treatment
by: Roy, N., et al.
Published: (2016)
by: Roy, N., et al.
Published: (2016)
Benzalhydantoin derivative-based inhibitors of eight receptor tyrosine kinases: synthesis, in-vitro, and in-silico study
by: Muhammad Naufal,, et al.
Published: (2025)
by: Muhammad Naufal,, et al.
Published: (2025)
Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012)
by: Sikka, S., et al.
Published: (2012)
Benzimidazole derivatives as potential dual inhibitors for poly (adp-ribose) polymerase-1 and dihydroorotate
dehydrogenase / Iskandar Abdullah
by: Iskandar, Abdullah
Published: (2015)
by: Iskandar, Abdullah
Published: (2015)
Synthesis, Characterization and Antimicrobial Studies of Some New Quinoline Incorporated Benzimidazole Derivatives
by: Hegde, Gurumurthy, et al.
Published: (2012)
by: Hegde, Gurumurthy, et al.
Published: (2012)
Self-assembling tyrosine kinase inhibitors for localised targeted delivery
by: Al-Ameedee, Mohammed
Published: (2017)
by: Al-Ameedee, Mohammed
Published: (2017)
Computational analysis on micro-shunt of minimally invasive glaucoma-surgery (MIGS) in severe glaucoma
by: Khairulfuaad, Riyadhthusollehan
Published: (2021)
by: Khairulfuaad, Riyadhthusollehan
Published: (2021)
The role of RhoH in TCR signalling and its involvement in diseases
by: Ahmad Mokhtar, Ana Masara, et al.
Published: (2021)
by: Ahmad Mokhtar, Ana Masara, et al.
Published: (2021)
Comparison of oxidative stress levels among patients with primary open angle glaucoma(POAG) and primary angle closure glaucoma (PACG) closure glaucoma (PACG)
by: Chan, Fhun Lai
Published: (2016)
by: Chan, Fhun Lai
Published: (2016)
Discovery of highly potent and selective phosphatidylinositol 3-kinase-δ inhibitors for the treatment of blood cancers and autoimmune diseases
by: Buzrieda, Anas
Published: (2021)
by: Buzrieda, Anas
Published: (2021)
Resistance mechanisms causing first-line epidermal growth factor receptor-tyrosine kinase inhibitor treatment failure
by: Chai, C.S., et al.
Published: (2017)
by: Chai, C.S., et al.
Published: (2017)
Molecular docking analysis on the designed benzimidazole derivatives as EGFR inhibitors: comparison between EGFR wild-type (EGFRWT) and T790M mutant
by: Nurul Awani Syazzira Jalil,, et al.
Published: (2023)
by: Nurul Awani Syazzira Jalil,, et al.
Published: (2023)
The effect of 24-hour intraocular pressure fluctuation
on glaucoma progression in primary angle closure glaucoma
by: A.Rahim @ Samsuddin, Haslinda
Published: (2015)
by: A.Rahim @ Samsuddin, Haslinda
Published: (2015)
Evaluation of transcriptional cyclin dependent kinase inhibitors as potential cancer therapeutics
by: Liu, Xiangrui
Published: (2012)
by: Liu, Xiangrui
Published: (2012)
An apoferritin-based drug delivery system for the tyrosine kinase inhibitor gefitinib
by: Kuruppu, Anchala I., et al.
Published: (2015)
by: Kuruppu, Anchala I., et al.
Published: (2015)
Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)
by: Falasca, Marco
Published: (2011)
An assessment of optic nerve parameters in
Malay normal tension glaucoma and
Primary open angle glaucoma patients
by: Rahim, Adlina Abdul
Published: (2012)
by: Rahim, Adlina Abdul
Published: (2012)
A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2017)
by: Dai, X., et al.
Published: (2017)
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
by: Siveen, K., et al.
Published: (2013)
by: Siveen, K., et al.
Published: (2013)
Activity of the aurora kinase B inhibitor AZD1152 in acute myeloid leukaemia
by: Grundy, Martin
Published: (2012)
by: Grundy, Martin
Published: (2012)
EGFR-directed tyrosine kinase inhibitors for non-small cell lung cancer
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
Purification of bacterial membrane sensor kinases and biophysical methods for determination of their ligand and inhibitor interactions
by: Hussain, Rohanah, et al.
Published: (2016)
by: Hussain, Rohanah, et al.
Published: (2016)
Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
by: Gunosewoyo, Hendra, et al.
Published: (2013)
by: Gunosewoyo, Hendra, et al.
Published: (2013)
Antidepressant, analgesic activity and SAR studies of substituted benzimidazoles
by: Siddiqui, Nadeem, et al.
Published: (2016)
by: Siddiqui, Nadeem, et al.
Published: (2016)
Synthesis and biological activity of 1,3,5-triazino[1,2-a]benzimidazol-2-amines.
by: Dolzhenko, Anton, et al.
Published: (2007)
by: Dolzhenko, Anton, et al.
Published: (2007)
Green synthesis of benzimidazole scaffolds using copper-substituted zinc aluminate in a sol-gel process
by: Kadam, Uttam D., et al.
Published: (2025)
by: Kadam, Uttam D., et al.
Published: (2025)
Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways
by: Kannaiyan, R., et al.
Published: (2011)
by: Kannaiyan, R., et al.
Published: (2011)
γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
by: Rajendran, P., et al.
Published: (2011)
by: Rajendran, P., et al.
Published: (2011)
Similar Items
-
Pathophysiological role of RhoA/Rho-kinase under oxygen-glucose deprivation/reperfusion and hyperglycaemia
by: Srivastava, Kirtiman
Published: (2013) -
Roles of Rho-associated kinase in lung cancer review
by: Zakaria, Muhammad Asyaari, et al.
Published: (2020) -
Synthesis And Biological Activity Of Benzimidazole Analogs As Sirtuin Enzyme Inhibitors
by: Yeong, Keng Yoon
Published: (2016) -
Synthesis of new 1,2-disubstituted benzimidazole analogs as potent inhibitors of Î-Glucuronidase and in silico study
by: Muhammad Taha, et al.
Published: (2021) -
The adaptor protein 14-3-3 binds to the calcium-sensing receptor and attenuates receptor-mediated Rho kinase signalling
by: Arulpragasam, Ajanthy, et al.
Published: (2012)